Amgen cancer drug OKd by EU
From Times Wire Services
Amgen Inc. received European Commission approval to market its drug Vectibix for use by colon cancer patients after standard chemotherapy procedures fail.
The clearance was based on a positive risk/benefit ratio for seriously ill patients who have few treatment options, the Thousand Oaks-based company said.
